Improving Care and Mental Well-Being for Adults With Heart Failure

Inclusion Criteria

• •For Patients (Surveys and Optional Interviews):
• •Patients at risk of heart failure (e.g., irregular heartbeat, coronary artery disease, a past heart attack, high blood pressure that is being treated, cardiomyopathy), or with a self-reported/documented diagnosis of heart failure OR on the following list of medications :
• •* Angiotensin receptor-neprilysin inhibitors (ARNI), called sacubitril-valsartan
• •* Angiotensin converting enzyme inhibitors (ACEi), called "prils"
• •* Angiotensin-receptor blockers (ARBs), called "sartans"
• •* Beta-blockers, called "lols"
• •* Mineralocorticoid receptor antagonists (MRAs)
• •* Sodium-glucose co-transporter-2 (SGLT2) inhibitors, called "flozins"
• •Receiving care at one of the participating pilot test sites or if they found their way to the tool website
• •Willing and able to provide informed consent and name, email address and phone number for follow-up contact (for survey and interview)
• •Caregivers (Optional interviews):
• •Caregivers who support adult(s) with heart failure.